ArticleJournal of medicine and life2025
Mixed-phenotype acute leukemia, not otherwise specified, rare types B/T leukemia: a case report in the Jordanian Royal Medical Services.
Article in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mixed phenotype acute leukemia (MPAL) represents approximately 3-5% of all acute leukemia cases and is defined by blast populations that co-express markers from more than one hematopoietic lineage. In most cases, blasts exhibit myeloid markers together with either B-cell or T-cell markers. The rarest subtype is mixed B/T acute leukemia. We report the case of a 7-year-old boy who presented with weakness and fatigue and was diagnosed with MPAL, not otherwise specified, B/T rare type, based on bone marrow examination and immunophenotyping. This case highlights the essential role of comprehensive immunophenotyping in establishing an accurate diagnosis of MPAL. Given the limited information in the literature, case series and prospective studies are needed for a better understanding and successful treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.